Vehik, Kendra http://orcid.org/0000-0001-6243-6772
,
Lynch, Kristian F.
Wong, Matthew C.
Tian, Xiangjun
Ross, Matthew C.
Gibbs, Richard A.
Ajami, Nadim J.
Petrosino, Joseph F.
Rewers, Marian
Toppari, Jorma
Ziegler, Anette G.
She, Jin-Xiong
Lernmark, Ake http://orcid.org/0000-0003-1735-0499
Akolkar, Beena
Hagopian, William A.
Schatz, Desmond A.
Krischer, Jeffrey P.
Hyƶty, Heikki
Lloyd, Richard E.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01/UC4 DK63821, UL1 TR001082, UC4 DK63863, U01/UC4 DK63836, U01/UC4 DK63865, U01/UC4 DK63861, U01/UC4 DK63829, UL1 TR000064, U01 DK63790, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483, HHSN267200700014C, U01 DK63863)
Article History
Received: 18 June 2019
Accepted: 25 October 2019
First Online: 2 December 2019
Competing interests
: H.H. is a shareholder and chairman of the board of Vactech, and a member of the Scientific Advisory Board of Provention Bio, which develops vaccines against picornaviruses and CVB. The authors have no other relevant affiliations, nor financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.